The NIH Strategic Plan for Tickborne Disease Research, October 9, 2019, is good news for everyone in the Lyme and tick-borne diseases community! The plan builds on the activities of the Department of Health and Human Services Tick-Borne Disease Working Group (TBDWG), which issued a 2018 report to Congress outlining research recommendations. Through inventories sent […]
This section contains information on legislation that has been introduced and/or passed by the federal government and individual states. It includes sections that contain the position the Lyme Disease Association has taken on various bills, if any; information on how to contact your legislator; and what you can do to help specific laws be passed or defeated. Additionally, there is a section on various government departments. From time to time, the LDA will post articles from the departments/agencies in these sections that pertain to Lyme disease that might be of interest or importance to the public, including policies being considered or adopted.
It is important for the LDA to take a lead role in forming relationships with all levels of government. Laws and policy decisions often affect how Lyme disease is viewed by the public and physicians, and LDA needs to clearly articulate the problems which are created by government actions or which can be rectified by government actions. Additionally, we need to ensure that the information presented to government officials is accurate and supported by science.
The tenth meeting of the Tick-Borne Disease Working Group (TBDWG) was held via webcast on Sept 12, 2019 from 9:00 a.m. to 3:00 p.m. ET. Subcommittee members were announced, and the Working Group received reports from the eight subcommittees that were formed during the June 4, 2019 meeting. Two subcommittee name changes were […]
The CDC formally recommends several new serologic assay testing methods recently cleared by the FDA. The Lyme disease serologic assays, which utilize a sensitive enzyme immunoassay (EIA) for detecting pathogens, were cleared by the FDA on July 29th, 2019 and have since been determined to be acceptable alternatives for the serologic diagnosis of Lyme disease […]
As part of the Pentagon’s second annual “Bug Week,” an event organized to raise awareness of insects and the diseases they carry, the Defense Department announced its plans to develop a new and improved product that will eventually replace permethrin, the repellent and insecticide currently used to soak most military combat uniforms to protect against […]
The Department of Health and Human Services (HHS) gave notice that the Tick-Borne Disease Working Group (TBDWG) will hold a public meeting via webcast on September 12, 2019, from 8:30 a.m. to 5 p.m. ET (times are tentative and subject to change). At the upcoming meeting, the TBDWG will receive updates from eight subcommittees that […]
On August 12, 2019, Illinois Governor, JB Pritzker, signed House Bill 889 into law which will expand insurance coverage for Lyme Disease testing and treatment. According to the Governor, this new legislation has been greatly needed and is a big step forward in protecting children and families throughout the state. Tick-borne illnesses have been on […]
TO: Lyme Disease Advocates & Patients FROM: Lyme Disease Association, Inc. Pat Smith, President, 8-15-19 RE: Urgent & Immediate Help Needed to Investigate Information Which Could Lead to Helping to Solve Tick-Borne Diseases Problem ISSUE: The debate over the prevalence of Lyme disease and whether it exists in a chronic form has raged for decades. […]
The federal Tick-Borne Disease Working Group (TBDWG) held their ninth meeting in D.C. on June 4, 2019 with a focus on developing the next report to be drafted for the HHS Secretary and Congress. The report will include an update on federal tick-borne disease activities and research findings. Read Meeting Summary and Written Public Comments […]
The Lyme Disease Association announces that the Food and Drug Administration (FDA) yesterday cleared for marketing four previously cleared tests for the diagnosis of Lyme disease. Called the modified two-tier, enzyme immune assay, (EIA), the new tests are able to be run at the same time or sequentially. The current two-tier testing has an EIA […]
Congressman Christopher Smith (R-NJ-04) has been pushing for funding and recognition of Lyme and tick-borne diseases over the past 27 years. On July 9, 2019, Mr. Smith testified before the Committee on Rules and introduced two amendments relating to Lyme and tick-borne diseases to the Defense Authorization Bill (National Defense Appropriations Act). ONE PASSED RULES […]